RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Stockholders' equity

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$82.2B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 202429,354+13.02%
Dec 31, 202325,973+14.60%
Dec 31, 202222,664+20.75%
Dec 31, 202118,769+70.23%
Dec 31, 202011,025-0.58%
Dec 31, 201911,090+26.63%
Dec 31, 20188,757+42.53%
Dec 31, 20176,144+38.09%
Dec 31, 20164,449+21.74%
Dec 31, 20153,655+43.76%
Dec 31, 20142,542+30.24%
Dec 31, 20131,952+56.74%
Dec 31, 20121,245+156.39%
Dec 31, 2011486-7.97%
Dec 31, 2010528

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)